Invitation Letter
    Contact Us
     Welcome Note
     Congress Chairpersons
     Scientific Committee
     Scientific Program
     Young Investigators Posters
         Submission Guidelines
         Poster Presentation Guidelines
         Award Ceremony
         Poster Texts
         Invitation Letter
     Sponsorship & Exhibition
         Hotel Rey Juan Carlos
         Hotel Senator Barcelona
     General Information
         Before you travel...
         Italian Agent
         Tips and Hints
     About Barcelona
1st World Congress on
Controversies in the Management of Viral Hepatitis (C-Hep)
Palau de Congressos de Catalunya, Barcelona, Spain, 19-22 May, 2011
  Fabien Zoulim Print

Fabien Zoulim
Professor of Medicine, Lyon University
Medical Director, Hepatology Department at the Hospices Civils de Lyon, France
Scientific Director, Viral Hepatitis Research Laboratory, INSERM U1052, Lyon, France

Fabien Zoulim obtained his M.D. in Gastroenterology and Hepatology in Lyon Medical School in 1991. He has also obtained a PhD in Molecular and Cellular Biology and was trained as a post-doctoral researcher at Fox Chase Cancer Center in Philadelphia. He has been a Professor of Medicine at Lyon I University since 1997. He is currently Medical Director of the Hepatology Department at the Hospices Civils de Lyon, and Scientific Director of the Department of Immunology and Virology of INSERM Unit 1052 where he is leading the team on ‘Antiviral therapy of viral hepatitis’. Dr Zoulim has served as an Associate Editor for Journal of Hepatology and is currently Associate Editor for Gut. He is a member of the editorial board of Hepatology, Antimicrobial Agents and Chemotherapy, and Antiviral Research. He also served as an expert in the microbiology study section of the INSERM, and in different national and international committees. He is also a member of European Association for the Study of the Liver (EASL) Governing Board. Dr Zoulim received the William Prusoff award of the International Society for Antiviral Research in recognition of his work in the field of HBV molecular biology and anti-HBV therapy. Furthermore, he has been the scientific coordinator of a European community-funded Network of Excellence, Virgil, on the management of antiviral drug resistance, and is currently involved in several European projects. Fabien Zoulim is a recognised expert in the field of anti-HBV therapy and drug resistance. He has published more than 245 articles in the field of viral hepatitis and antiviral therapy.

Home    Contact Us   
Copyright © 2007 comtecmed.com. All rights reserved.   The website was last updated on 10/16/2011 Created by     WebStudio.co.il